Tag Archive for: London

Advanced Therapies Europe will educate and inspire cell and gene therapy professionals in Europe, and those who wish to enter into the European market.

FreeMind is a proud supporter of the upcoming Inv€$tival Showcase

Where: London, UK
When: November 14, 2017

Showcasing innovative investable Biotech, Medtech and Digital Health investment and partnering opportunities.

Biotech and Money connects corporates to capital, and the Inv€$tival Showcase is our most direct way of showcasing the latest investable private and public life science opportunities to our growing investor network, and that of our partners, Jefferies LLC.

The 4 track Inv€$tival Showcase is designed to highlight the latest innovative companies who are looking to raise capital and their profile amongst investors, and provide an unparalled opportunity for 1-2-1 investor and B2B meetings in a unique setting, and as part of the week of the Jefferies Global Healthcare conference in London. The 4 tracks are split into industry sub-sectors, with sections for companies working within the fields of immuno-oncology, cell and gene therapy, precision medicine, neuroscience / CNS, orphan drugs, digital health and medical devices, as well as an agnostic section for other industry sub-sectors. Presenting companies will range from the latest start-ups through to growing public companies, delivering succinct powerful presentations to an audience of qualified investors.

FreeMind is proud to support the upcoming Investment for Advanced Therapies event!

When: May 3, 2017
Where: London, UK

Investment for Advanced Therapies will be the C-Level meeting place for heavyweight investors, analysts, biotechs, venture partners and industry experts who are driving the industry forward. Don’t miss your chance to shape the future and put your company on the map!

This one-day, highly interactive program will:

• Explain the market outlook and address specific questions regarding investment and licensing opportunities in advanced therapies

• Provide institutional, strategic and venture investors with unique insight into financing hypothesis for advanced therapies

• Showcase a cross section of early stage, pre-IPO, late stage and public biotech companies and provide extensive networking opportunities

• Introduce senior executives from biopharmaceutical companies to explain how investors can profit from the development of the advanced therapies franchise

• Promote and facilitate investment, financing, partnerships and deal making in
the cell and gene therapy field

Visit here for more information.